BP

Biswajit Pan

Active Director Director DIN 08473723
DIN 08473723 First appointment Jun 2019 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Past companies 1 historical roles
Total affiliations 9 Since Jun 2019
Shareholding value •••• Premium profile

About Biswajit Pan

Data last updated:

Biswajit Pan has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 8 companies, including Alventa Pharma Limited and Aleris Pharmaceuticals Limited. Formerly with 1 company, such as Concept Biosciences India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹426 Cr; the largest is Allenburys Pharma Limited at ₹159 Cr (FY 2025).

DIN 08473723
Primary Designation Director
First Appointment 07 Jun 2019
Oldest Company Age 9 yrs
Largest company Allenburys Pharma Limited · ₹159 Cr (FY 2025)
Combined revenue ₹426 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Allenburys Pharma Limited U93020WB2020PLC240519
Director15 Oct 20202020₹159 Cr (FY 2025)Active
Alventa Pharma Limited U24299WB2016PLC225674
Director07 Jun 20192016₹143 Cr (FY 2025)Active
Aleris Pharmaceuticals Limited U24304WB2021PLC245141
Director13 May 20212021₹75.07 Cr (FY 2025)Active
Elder Laboratories Limited U24309WB2021PLC245140
Director13 May 20212021₹49.51 Cr (FY 2024)Active
Nicholas Pharma India Limited U85100WB2021PLC244244
Director30 Mar 20212021₹40,000 (FY 2023)Active
Designated Partner08 Feb 20262026–Active
Designated Partner29 Jul 20252024–Active
Designated Partner02 Jul 20252025–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20192008₹114 Cr (FY 2019)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alventa Pharma Limited
Aleris Pharmaceuticals Limited
Elder Laboratories Limited
Nicholas Pharma India Limited
Premium access

Shareholding and investment profile for Biswajit Pan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswajit Pan

Biswajit Pan has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 8 companies, including Alventa Pharma Limited and Aleris Pharmaceuticals Limited. Formerly with 1 company, such as Concept Biosciences India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹426 Cr; the largest is Allenburys Pharma Limited at ₹159 Cr (FY 2025).

Biswajit Pan is associated with 8 companies as Director and Designated Partner, including Allenburys Pharma Limited (₹159 Cr), Alventa Pharma Limited (₹143 Cr), Aleris Pharmaceuticals Limited (₹75.07 Cr).

Biswajit Pan has expertise in General Business, Healthcare.

Biswajit Pan has 7 years in corporate governance.

By reported revenue, the largest current company of Biswajit Pan is Allenburys Pharma Limited, with revenue of ₹159 Cr (FY 2025).

The 5 current companies of Biswajit Pan that report revenue have a combined latest revenue of ₹426 Cr.

Biswajit Pan currently holds positions at 8 companies; the 5 largest by reported revenue are Allenburys Pharma Limited (₹159 Cr), Alventa Pharma Limited (₹143 Cr), Aleris Pharmaceuticals Limited (₹75.07 Cr), Elder Laboratories Limited (₹49.51 Cr), Nicholas Pharma India Limited (₹40,000).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available